AV

Ashutosh Vinay Jha

Active Director Whole-Time Director DIN 08284476
DIN 08284476 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashutosh Vinay Jha

Data last updated:

Ashutosh Vinay Jha is a Whole-Time Director at Qualito Pharmaceuticals Private Limited (since 2018). The company operates in Pharma.

DIN 08284476
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 30 Nov 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director30 Nov 20182018Active

Board colleagues of Ashutosh Vinay Jha

NameDINCompanyDesignation
Abhishek Ashutosh Kumar Jha07708145Qualito Pharmaceuticals Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Qualito Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashutosh Vinay Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashutosh Vinay Jha

Ashutosh Vinay Jha currently holds 1 directorship: Qualito Pharmaceuticals Private Limited (Whole-Time Director, since 30 Nov 2018).

Ashutosh Vinay Jha was first appointed on 30 Nov 2018 as Whole-Time Director at Qualito Pharmaceuticals Private Limited.

The current boards of Ashutosh Vinay Jha's companies include Abhishek Ashutosh Kumar Jha (Qualito Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available